30 results
424B3
YBGJ
Yubo International Biotech Ltd
1 Aug 22
Prospectus supplement
6:04am
success of Yubo Beijing’s products depends upon the degree of their market acceptance among the medical community. If Yubo Beijing’s products do … not attain market acceptance among the medical community, its operations and profitability would be adversely affected. See page 33 of this prospectus.
We
S-1/A
n0s560 nyh7wny8p991
12 Jul 21
IPO registration (amended)
4:50pm
S-1
tfp50 34rif
6 May 21
IPO registration
6:03am
10-KT
i0umrz qoyie48sn
23 Apr 21
Annual report (with FYE transition)
5:05pm
DEF 14C
cantv9uix4a040dyod
24 Mar 21
Information statement
4:13pm
PRE 14C
kez3h 5gqw
12 Mar 21
Preliminary information
4:14pm
8-K
j96hbe2x f81sucqkk
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
DEF 14C
pjs cnj54h9dr4do3g
12 Nov 20
Information statement
1:41pm